Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 72

1.

Prognostic, predictive and potential surrogate markers in castration-resistant prostate cancer.

Aziz A, Kempkensteffen C, May M, Lebentrau S, Burger M, Chun FK, Brookman-May S.

Expert Rev Anticancer Ther. 2015 Apr 23:1-18. [Epub ahead of print]

PMID:
25905802
2.

[Malignant Sertoli cell tumors of the testes].

Günzel K, Wegner H, Cash H, Lohneis P, Kempkensteffen C, Miller K, Hinz S.

Urologe A. 2015 Mar 28. [Epub ahead of print] German.

PMID:
25821170
3.

Evaluation of perioperative complications in open and laparoscopic surgery for renal cell cancer with tumor thrombus involvement using the Clavien-Dindo classification.

Ebbing J, Wiebach T, Kempkensteffen C, Miller K, Bachmann A, Günzel K, Rieken M, Friedersdorff F, Baumunk D, Weikert S.

Eur J Surg Oncol. 2015 Mar 11. pii: S0748-7983(15)00082-7. doi: 10.1016/j.ejso.2015.02.009. [Epub ahead of print]

PMID:
25817982
4.

[Propensity score comparison of the various radical surgical techniques for high-risk prostate cancer].

Busch J, Gonzalgo M, Leva N, Ferrari M, Friedersdorff F, Hinz S, Kempkensteffen C, Miller K, Magheli A.

Aktuelle Urol. 2015 Jan;46(1):45-51. doi: 10.1055/s-0034-1395562. Epub 2014 Dec 19. German.

PMID:
25526221
5.

Matched comparison of robot-assisted, laparoscopic and open radical prostatectomy regarding pathologic and oncologic outcomes in obese patients.

Busch J, Gonzalgo ML, Leva N, Ferrari M, Cash H, Kempkensteffen C, Hinz S, Miller K, Magheli A.

World J Urol. 2015 Mar;33(3):397-402. doi: 10.1007/s00345-014-1326-1. Epub 2014 May 23.

PMID:
24853030
6.

An epigenetic screen unmasks metallothioneins as putative contributors to renal cell carcinogenesis.

Alkamal I, Ikromov O, Tölle A, Fuller TF, Magheli A, Miller K, Krause H, Kempkensteffen C.

Urol Int. 2015;94(1):99-110. doi: 10.1159/000357282. Epub 2014 Mar 20.

PMID:
24662736
7.

Optimizing evaluation of split renal function in a living kidney donor using scintigraphy and calculation of the geometric mean: a case report.

Weinberger S, Bäder M, Scheurig-Münkler C, Hinz S, Neymeyer J, Miller K, Kempkensteffen C.

Case Rep Nephrol Urol. 2014 Jan 10;4(1):1-4. doi: 10.1159/000358007. eCollection 2014 Jan.

8.

Urinary calprotectin: a new diagnostic marker in urothelial carcinoma of the bladder.

Ebbing J, Mathia S, Seibert FS, Pagonas N, Bauer F, Erber B, Günzel K, Kilic E, Kempkensteffen C, Miller K, Bachmann A, Rosenberger C, Zidek W, Westhoff TH.

World J Urol. 2014 Dec;32(6):1485-92. doi: 10.1007/s00345-013-1227-8. Epub 2013 Dec 31.

PMID:
24378824
9.

Higher rates of upgrading and upstaging in older patients undergoing radical prostatectomy and qualifying for active surveillance.

Busch J, Magheli A, Leva N, Ferrari M, Kramer J, Klopf C, Kempkensteffen C, Miller K, Brooks JD, Gonzalgo ML.

BJU Int. 2014 Oct;114(4):517-21. doi: 10.1111/bju.12466. Epub 2014 Jan 22.

PMID:
24112652
10.

Interdisciplinary decision making in prostate cancer therapy - 5-years' time trends at the Interdisciplinary Prostate Cancer Center (IPC) of the Charité Berlin.

Baumunk D, Reunkoff R, Kushner J, Baumunk A, Kempkensteffen C, Steiner U, Weikert S, Moser L, Schrader M, Höcht S, Wiegel T, Miller K, Schostak M.

BMC Med Inform Decis Mak. 2013 Aug 5;13:83. doi: 10.1186/1472-6947-13-83.

11.

Diagnostic and prognostic potential of differentially expressed miRNAs between metastatic and non-metastatic renal cell carcinoma at the time of nephrectomy.

Wotschofsky Z, Busch J, Jung M, Kempkensteffen C, Weikert S, Schaser KD, Melcher I, Kilic E, Miller K, Kristiansen G, Erbersdobler A, Jung K.

Clin Chim Acta. 2013 Feb 1;416:5-10. doi: 10.1016/j.cca.2012.11.010. Epub 2012 Nov 21.

PMID:
23178446
12.

Long-term outcomes of living donor kidney transplants in pediatric recipients following laparoscopic vs. open donor nephrectomy.

Chaykovska L, Deger S, Roigas J, Lenz A, Lioudmer P, Kothmann LT, Friedersdorff F, Müller D, Kasper A, Giessing M, Magheli A, Kempkensteffen C, Lingnau A, Fuller TF.

Pediatr Transplant. 2012 Dec;16(8):894-900. doi: 10.1111/petr.12008.

PMID:
23131058
13.

Retrospective comparison of triple-sequence therapies in metastatic renal cell carcinoma.

Busch J, Seidel C, Erber B, Issever AS, Hinz S, Kempkensteffen C, Magheli A, Miller K, Grünwald V, Weikert S.

Eur Urol. 2013 Jul;64(1):62-70. doi: 10.1016/j.eururo.2012.09.004. Epub 2012 Sep 11.

PMID:
22999519
14.

Outcome of expanded criteria donor kidneys that were transplanted at other Eurotransplant centers after being rejected by our institution.

Friedersdorff F, Roller C, Klein G, Werthemann P, Cash H, Budde K, Slowinski T, Kempkensteffen C, Busch J, Fuller TF, Giessing M.

World J Urol. 2013 Aug;31(4):947-52. doi: 10.1007/s00345-012-0929-7. Epub 2012 Aug 18.

PMID:
22903774
15.

Outcomes after laparoscopic living donor nephrectomy: comparison of two laparoscopic surgeons with different levels of expertise.

Friedersdorff F, Werthemann P, Cash H, Kempkensteffen C, Magheli A, Hinz S, Waiser J, Liefeldt L, Miller K, Deger S, Fuller TF.

BJU Int. 2013 Jan;111(1):95-100. doi: 10.1111/j.1464-410X.2012.11348.x. Epub 2012 Jul 3.

PMID:
22757693
16.

Long-term oncological and continence outcomes after laparoscopic radical prostatectomy: a single-centre experience.

Busch J, Stephan C, Herold A, Erber B, Kempkensteffen C, Hinz S, Lein M, Weikert S, Miller K, Magheli A.

BJU Int. 2012 Dec;110(11 Pt C):E985-90. doi: 10.1111/j.1464-410X.2012.11279.x. Epub 2012 Jun 6.

PMID:
22672442
17.

Laparoscopic and open postchemotherapy retroperitoneal lymph node dissection in patients with advanced testicular cancer--a single center analysis.

Busch J, Magheli A, Erber B, Friedersdorff F, Hoffmann I, Kempkensteffen C, Weikert S, Miller K, Schrader M, Hinz S.

BMC Urol. 2012 May 31;12:15. doi: 10.1186/1471-2490-12-15.

18.

Impact of positive surgical margins on oncological outcome following laparoscopic radical prostatectomy (LRP): long-term results.

Busch J, Stephan C, Klutzny A, Hinz S, Kempkensteffen C, Kilic E, Lein M, Weikert S, Miller K, Magheli A.

World J Urol. 2013 Apr;31(2):395-401. doi: 10.1007/s00345-012-0866-5. Epub 2012 May 11.

PMID:
22576695
19.

Selective lymph node dissection for castration-resistant prostate cancer.

Busch J, Hinz S, Kempkensteffen C, Erber B, Klopf C, Weikert S, Miller K, Magheli A.

Urol Int. 2012;88(4):441-6. doi: 10.1159/000335206. Epub 2012 Mar 7.

PMID:
22398510
20.

CYP3A5 genotype-phenotype analysis in the human kidney reveals a strong site-specific expression of CYP3A5 in the proximal tubule in carriers of the CYP3A5*1 allele.

Bolbrinker J, Seeberg S, Schostak M, Kempkensteffen C, Baelde H, de Heer E, Kreutz R.

Drug Metab Dispos. 2012 Apr;40(4):639-41. doi: 10.1124/dmd.111.042648. Epub 2012 Jan 3.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk